POLARIX Trial: Pola-R-CHP Shows Clear Benefit in Specific DLBCL Subtypes丨Dr. Eleonora Calabretta on the Role of DLBclass
Editor's Note: At a highly anticipated hematologic oncology conference, the Late-Breaking Abstract (LBA) session became a focal point. Co-chaired by Professor Kim Linton from the University of Manchester and Professor…








